Form 8-K - Current report:
SEC Accession No. 0001104659-25-067561
Filing Date
2025-07-14
Accepted
2025-07-14 07:01:23
Documents
14
Period of Report
2025-07-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2520584d1_8k.htm   iXBRL 8-K 34627
2 EXHIBIT 3.1 tm2520584d1_ex3-1.htm EX-3.1 8624
3 EXHIBIT 99.1 tm2520584d1_ex99-1.htm EX-99.1 10616
  Complete submission text file 0001104659-25-067561.txt   231086

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pasg-20250710.xsd EX-101.SCH 3020
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20250710_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20250710_pre.xml EX-101.PRE 22362
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2520584d1_8k_htm.xml XML 3943
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

EIN.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 251120121
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)